CHRS(CHRS)
CHRS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $62M | $88M | $184M | $264M | $360M |
| Low | $43M | $71M | $180M | $204M | $278M |
| High | $105M | $105M | $189M | $381M | $520M |
| EBITDA Avg | $-41M | $-59M | $-123M | $-175M | $-239M |
| Low | $-70M | $-70M | $-125M | $-253M | $-345M |
| High | $-29M | $-47M | $-120M | $-135M | $-185M |
| EBIT Avg | $-42M | $-59M | $-124M | $-178M | $-242M |
| Low | $-71M | $-71M | $-127M | $-257M | $-350M |
| High | $-29M | $-48M | $-121M | $-137M | $-187M |
| Net Income Avg | $-159M | $-88M | $-83M | $-17M | $41M |
| Low | $-193M | $-121M | $-89M | $-26M | $29M |
| High | $-86M | $-54M | $-34M | $-12M | $64M |
| EPS Avg | $-1.01 | $-0.64 | $-0.48 | $-0.14 | $0.34 |
| Low | $-1.60 | $-1.01 | $-0.74 | $-0.22 | $0.24 |
| High | $-0.71 | $-0.45 | $-0.28 | $-0.10 | $0.53 |
| Analysts (Rev / EPS) | 5 / 2 | 4 / 2 | 5 / 4 | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $17M | $19M | $22M | $25M | $29M | $34M | $42M | $44M |
| Low | $16M | $17M | $21M | $23M | $27M | $31M | $39M | $41M |
| High | $18M | $20M | $24M | $27M | $31M | $37M | $45M | $47M |
| EBITDA Avg | $-11M | $-12M | $-15M | $-16M | $-19M | $-22M | $-28M | $-29M |
| Low | $-12M | $-13M | $-16M | $-18M | $-21M | $-24M | $-30M | $-31M |
| High | $-10M | $-11M | $-14M | $-15M | $-18M | $-21M | $-26M | $-27M |
| EBIT Avg | $-11M | $-13M | $-15M | $-17M | $-20M | $-23M | $-28M | $-29M |
| Low | $-12M | $-14M | $-16M | $-18M | $-21M | $-25M | $-31M | $-32M |
| High | $-11M | $-12M | $-14M | $-16M | $-18M | $-21M | $-26M | $-27M |
| Net Income Avg | $-31M | $-35M | $-23M | $-23M | $-26M | $-26M | — | — |
| Low | $-35M | $-39M | $-26M | $-26M | $-29M | $-29M | — | — |
| High | $-29M | $-32M | $-21M | $-21M | $-24M | $-24M | — | — |
| EPS Avg | $-0.23 | $-0.26 | $-0.17 | $-0.17 | $-0.19 | $-0.19 | — | — |
| Low | $-0.26 | $-0.29 | $-0.19 | $-0.19 | $-0.21 | $-0.21 | — | — |
| High | $-0.21 | $-0.23 | $-0.15 | $-0.15 | $-0.17 | $-0.17 | — | — |
| Analysts (Rev / EPS) | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 | 2 / — | 1 / — |